期刊
JOURNAL OF FOOD BIOCHEMISTRY
卷 43, 期 1, 页码 -出版社
WILEY-HINDAWI
DOI: 10.1111/jfbc.12572
关键词
angiotensin-converting enzyme; angiotensin-converting enzyme inhibitory peptides; bioavailability cellular mechanisms; molecular docking; vascular endothelial cells; vascular smooth muscle cells
资金
- Natural Sciences and Engineering Research Council of Canada
- Egg Farmers of Canada
- China Scholarship Council
- Alberta Innovates Technology Features
- Burnbrae Farms Ltd.
Food-derived angiotensin-converting enzyme inhibitory (ACEi) peptides have gained substantial interest as potential alternatives to synthetic drugs in the management of hypertension. Peptide size and sequence are two critical factors that determine their potency, bioavailability, and cellular mechanisms. Molecular interaction studies between ACE and ACEi peptides support that potent ACEi peptides are generally composed of hydrophobic, positively charged, and aromatic or cyclic amino acid residues at the third, second, and first position from the C-terminus, respectively. Small peptides containing N-terminal Tyr and/or C-terminal Pro could improve their stability against enterocyte peptidases and, thus, their bioavailability. Different ACEi peptides can reduce aberrant cellular proliferation, excessive inflammation, and oxidative stress but through different mechanisms. Further understanding the structure-activity-bioavailability relationships will help design novel potent ACEi peptides with improved bioavailability and in vivo efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据